NCT03684343 Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of Age Status TERMINATED Phase NA
NCT03676933 Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03676036 Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03667014 The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients Status COMPLETED Phase PHASE4
NCT03661866 A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03661138 A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03654755 Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03646604 A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT03645057 ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03632174 Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic Dermatitis Status COMPLETED Phase NA
NCT03622463 A Trial of Antroquinonol in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03619161 Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema Status COMPLETED Phase NA
NCT03614221 Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03607422 A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2) Status COMPLETED Phase PHASE3
NCT03587805 Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND Status COMPLETED Phase PHASE3
NCT03585296 A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03581747 Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders Status UNKNOWN Phase N/A
NCT03571620 Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients Status COMPLETED Phase PHASE2